Over 800 Google Workers Demand the Company Cut Ties With ICE
UNL Student Government Passes SJP-Backed Israel Divestment Resolution
AOC Mourns the Loss of ’Our Media,’ More Layoffs Across the Industry (and...
The Left Just Doesn't Understand Why WaPo Is Failing
16 Years and $16 Billion Later the First Railhead Goes Down for CA's...
New Musical Remakes Anne Frank As a Genderqueer Hip-Hop Star
Toledo Man Indicted for Threatening to Kill Vice President JD Vance During Ohio...
Fort Lauderdale Financial Advisor Sentenced to 20 Years for $94M International Ponzi Schem...
FCC Is Reportedly Investigating The View
Illegal Immigrant Allegedly Used Stolen Identity to Vote and Collect $400K in Federal...
$26 Billion Gone: Stellantis Joins Automakers Retreating From EVs
House Oversight Chair: Clintons Don’t Get Special Treatment in Epstein Probe
Utah Man Sentenced for Stealing Funds Meant to Aid Ukrainian First Responders
Ex-Bank Employee Pleads Guilty to Laundering $8M for Overseas Criminal Organization
State Department Orders Evacuation of US Citizens in Iran As Possibility of Military...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos